Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Oncothyreon presents update on clinical development activities

Sep. 4, 2008

HGS reports initial top-line results from phase II HGS-ETR1 trial

Sep. 3, 2008

FDA notifies Introgen that Advexin BLA not sufficiently complete to file

Sep. 3, 2008

Novel dual HER1/HER2 inhibitor shows antitumor activity in vivo

Sep. 3, 2008

Preclinical studies show potential of CR-3294 in intestinal mucositis

Sep. 2, 2008

Oncolytics to initiate phase II combination clinical trial of Reolysin in NSCLC

Sep. 2, 2008

Lexicon team discovers potent deoxycytidine kinase inhibitor

Sep. 2, 2008

Merck describes synthesis of dual AKT1/2 inhibitor for cancer treatment

Sep. 2, 2008

Taxotere Injection approved in Japan for prostate cancer

Sep. 1, 2008

Overall survival results reported in Erbitux phase III lung cancer study

Sep. 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...